($77.07) beat EPS estimates by 9 cents earning 83 cents a share premarket on Tuesday. The buy-rated stock set a new multi-year high at $83.33 at Tuesday's open and then changed direction to a week's low at $76.65 on Thursday, which is below its 50-day SMA at $78.12. My annual value level is $64.34 with monthly and semiannual risky levels at $83.93 and $86.69.
($11.88) beat EPS estimates by 2 cents reporting a loss of 8 cents a share in afterhours trading on Tuesday. The hold-rated stock opened higher on Wednesday and traded as high as $11.92 for a failed test of its 200-day SMA at $11.88. The stock is above its 50-day SMA at $11.20 with my quarterly value level at $11.00 with an annual pivot at $11.49 and monthly risky level at $12.35.
($56.86) beat EPS estimates by 2 cents earning 49 cents a share in premarket trading on Wednesday. The buy-rated stock set a new multi-year high at $61.56 then changed direction with a week's low at $55.76 on Thursday, below its 50-day SMA at $58.22. My quarterly value level is $50.79 with a semiannual pivot, now a risky level at $59.42.
($12.50) beat EPS estimates by 7 cents reporting a loss of 25 cents a share in premarket trading on Wednesday. The stock opened with a moon-shot that continued on Thursday to a new multi-year high at $12.88. As a result of this spike the stock was downgraded to hold from buy. I do not show a risky level at this time.
At the time of publication the author had no position in any of the stocks mentioned.
This article was written by an independent contributor, separate from TheStreet's regular news coverage.